Economy

Should You Buy Neurocrine Biosciences, Inc. (NASDAQ:NBIX) On Current Analyst Views?

Should You Buy Neurocrine Biosciences, Inc. (NASDAQ:NBIX) On Current Analyst Views?”

(NASDAQ:PDFS) earned "Hold" rating by Craig Hallum on Friday, July 29. ValuEngine cut Neurocrine Biosciences from a "sell" rating to a "strong sell" rating in a report on Thursday, May 25th. Two investment analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the stock. Company insiders own 4.80% of the company's stock. The rating was initiated by Needham on Tuesday, October 18 with "Buy".

Neurocrine Biosciences, Inc is engaged in the development of pharmaceutical products focused on neurological and endocrine-based diseases and disorders. (NASDAQ:PDFS) to report earnings on October, 26. The rating was reinitiated by Jefferies with "Buy" on Tuesday, August 18. (NASDAQ:NBIX). Voya Invest Mngmt Limited Liability Company has 0% invested in Neurocrine Biosciences, Inc.

Tiverton Asset Management Llc increased Home Depot Inc/The (HD) stake by 31.42% reported in 2016Q4 SEC filing. Following the transaction, the insider now owns 123,045 shares in the company, valued at approximately $6,767,475. Next quarter's EPS is estimated at $-0.40 with next year's EPS anticipated to be $-1.73. Home Depot Inc/The now has $186.67 billion valuation. The stock decreased 0.39% or $0.06 on September 14, reaching $15.16. The shares were sold at an average price of $55.00, for a total value of $844,470.00. Home Depot Inc (NYSE:HD) has risen 18.65% since September 15, 2016 and is uptrending. It has outperformed by 86.57% the S&P500.

In an overview of the current analyst recommendations, Buy count is 12 and Overweight is 1 while the number of analysts recommending Sell and Underweight are 0 and 0, respectively. Bragg Financial Advisors Inc sold 33,616 shares as the company's stock 0.00%. About 1.25 million shares traded. The correct version of this piece can be read at https://www.dispatchtribunal.com/2017/09/14/neurocrine-biosciences-inc-nbix-receives-buy-rating-from-oppenheimer-holdings-inc.html. 15,000 shares valued at $810,000 were sold by Gano Kyle on Monday, May 1. Also, insider Christopher Flint Obrien sold 52,817 shares of the company's stock in a transaction on Tuesday, September 5th. Lloyd-Smith Malcolm sold $534,155 worth of stock. Following the sale, the insider now owns 144,601 shares in the company, valued at approximately $8,676,060. The stock has "Buy" rating by H.C. Wainwright on Friday, August 4. (NASDAQ:NBIX). Aperio Grp Ltd Liability invested in 0.01% or 24,014 shares. Its R&D focus is on addressing diseases and disorders of the central nervous and endocrine systems, which include therapeutic categories ranging from hypothalamic-pituitary-adrenal (HPA) disorders to stress-related disorders and neurological/neuropsychiatric disease. That puts the market capitalization at $5.02 bln. The Company's three lead late-stage clinical programs are elagolix, which is a gonadotropin-releasing hormone (GnRH) antagonist for endometriosis and uterine fibroids; INGREZZA (valbenazine), which is a vesicular monoamine transporter 2 (VMAT2) inhibitor, for the treatment of movement disorders, and opicapone, which is a selective catechol-O-methyltransferase inhibitor that is an adjunct therapy to preparations of levodopa/Dihydroxyphenylalanine (DOPA) decarboxylase inhibitors for adult patients with Parkinson's disease. It now has negative earnings.

Investors sentiment increased to 1.25 in Q4 2016. Its up 0.22, from 1.03 in 2016Q3. Piper Jaffray Companies reaffirmed an "overweight" rating and issued a $96.00 price target on shares of Neurocrine Biosciences in a report on Wednesday, December 7th. 23 funds opened positions while 83 raised stakes. Dynamic Capital Mngmt Ltd invested in 45,928 shares or 0.19% of the stock. State Bank Of New York Mellon invested 0.02% of its portfolio in Neurocrine Biosciences, Inc. (NASDAQ:NBIX). Jpmorgan Chase & Commerce stated it has 0.01% in Neurocrine Biosciences, Inc. Polar Llp accumulated 597,256 shares. Moreover, Schroder Mngmt Group Inc has 0% invested in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) was sold by Grigoriadis Dimitri E. on Tuesday, May 23. (NASDAQ:PDFS) for 32,799 shares. Qs Investors Limited Liability Com owns 9 shares. Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Invest Mgmt holds 52,245 shares.

10/08/2015 - Neurocrine Biosciences, Inc. had its "buy" rating reiterated by analysts at JP Morgan. The institutional investor held 10,709 shares of the property-casualty insurers company at the end of 2016Q4, valued at $990,000, down from 44,325 at the end of the previous reported quarter. It has underperformed by 4.19% the S&P500.

Among 28 analysts covering The Home Depot Inc. RYAN JOHN T III also sold $257,294 worth of MSA Safety Incorporated (NYSE:MSA) on Monday, May 8. Therefore 71% are positive.

Ratings analysis reveals 50% of Neurocrine Biosci's analysts are positive. The stock of Endurance Specialty Holdings Ltd. (NYSE:ENH) earned "Mkt Perform" rating by Keefe Bruyette & Woods on Friday, October 7. More interesting news about Neurocrine Biosciences, Inc. FBR Capital maintained the shares of XPO in report on Friday, August 7 with "Outperform" rating.

Among 5 analysts covering Endurance Specialty Holding (NYSE:ENH), 1 have Buy rating, 0 Sell and 4 Hold.

05/24/2017 - Neurocrine Biosciences, Inc. had its "outperform" rating reiterated by analysts at BMO Capital Markets. (NASDAQ:DXCM) are 1.57%; 1.59% for the month; -4.31% for the last quarter; -6.5% for the past six-months; and -21.18% for the last 12 months.



Like this

Latest


17 September 2017
Australia call up Handscomb as cover for injured Finch
Smith feels the Chennai surface is likely to be full of runs and highlighted the importance of big runs from the top order. Six alternatives have been tried and now both Smith and coach David Saker reckons that Travis is apot for the spot.

17 September 2017
BidaskClub Lowers SunCoke Energy Partners, LP (SXCP) to Sell
Equities analysts forecast that SunCoke Energy Partners, L.P. will post ($1.91) EPS for the current fiscal year. Zurcher Kantonalbank (Zurich Cantonalbank) stated it has 0% of its portfolio in SunCoke Energy Inc (NYSE:SXC).

17 September 2017
LivaNova PLC (LIVN) Stock Rating Upgraded by Needham & Company LLC
They now have a $83.00 target on shares. and their target would suggest a possible upside of 21.93 % over the current stock price. Investors are more bullish on LivaNova PLC - Ordinary Shares of late if you put credence in the decrease in short interest.

17 September 2017
Clement: Wembley outing will inspire Swansea
Swansea City manager Paul Clement is "very proud" of his players following their goalless draw with Tottenham Hotspur at Wembley.

17 September 2017
Pettway's 3TD performance pushes No. 15 Auburn past Mercer
James sustained the injury when left guard Mike Horton fell on his back on a 3-yard run by running back Kamryn Pettway . Next up, Auburn opens its SEC schedule on the road at Missouri. "We had five turnovers, but it's nothing we can't fix".

17 September 2017
Fantasy Cricket: TFG Pundit tips for England v West Indies T20
However, the Windies can now ill afford to lose any of the contests against England , leaving them with little margin of error. Brathwaite didn't not feature in the preceding Test series, which England claimed 2-1 after winning the 3rd Test at Lord's.

17 September 2017
New Apple mobile chip leaves the competition behind
These devices will be available from leading dealers, major e-commerce sites and Apple's own authorised resellers. Apple allows all 6 to be used at the same time, something which it chose not to do with the A10 Fusion.

17 September 2017
North Korea does it again: Fires missile over Japan on Friday
President Donald Trump said he was briefed on the situation. "Numerous things happening, including North Korea", he said. Security Council imposed its toughest-ever sanctions on North Korea to punish the country for its sixth nuclear test.

17 September 2017
Ryan says Trump made right call on immigrants
During his presidential campaign and since, Trump has repeatedly promised to build a wall along the U.S. -Mexico border. Trump has announced that he'll dismantle the Obama administration's program in six months .

17 September 2017
US Coercive Approach Not to Work in Case of Iran: Leader
Khamenei criticized the United States officials, saying that corrupt and lying U.S. officials blatantly accuse Iran of lying.



Recommended